Testing effectiveness (Phase 2)Study completedNCT02772276
What this trial is testing
Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types
Who this might be right for
Acute Kidney Injury
MediBeacon 234